A groundbreaking new course at Rutgers University–Camden is providing undergraduate students firsthand experience presenting research to peers and colleagues at no additional cost beyond their tuition dollars.
A study from Rutgers Cancer Institute researchers in eClinicalMedicine is the first to link ultra-processed foods to reduced survival in Black women with breast cancer.
Rutgers, The State University of New Jersey, has granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize PW507, a novel class of compounds created by researchers at Rutgers with the potential to transform pain management and reduce the opioid epidemic.
The Rutgers plant biologist was elected to the 2025 Class of the National Academy of Inventors (NAI). The Office for Research's Technology Transfer team worked extensively on the application and submitted the nomination to the NAI.
The program will train physician-scientists to focus on new drug development and early disease detection when intervention has the greatest potential to alter long-term outcomes.
Rutgers researchers find most state residents have used at least one artificial intelligence tool and see the technology as helpful, but many say it will eliminate more jobs than it creates.
The rise of the body positivity movement in the 2010s created greater acceptance of the idea that a healthy body can come in a variety of weights, shapes, and sizes. Now, in the era of GLP-1s, the conversation may be changing yet again.
Voters show confidence in navigating health insurance, but continue to grapple with a system they view as complicated, costly, and shaped by forces beyond their control.